🔗 Share this article

This year's prestigious award in Physiology or Medicine was granted for revolutionary discoveries that illuminate how the body's defense network targets harmful pathogens while protecting the healthy tissues.

Three esteemed researchers—Japan's Shimon Sakaguchi and American scientists Mary Brunkow and Dr. Ramsdell—received this accolade.

The work uncovered unique "security guards" within the defense system that remove rogue immune cells that could attacking the organism.

The discoveries are now paving the way for new therapies for autoimmune diseases and cancer.

The winners will divide a prize fund worth 11 million Swedish kronor.

Decisive Findings

"Their research has been essential for comprehending how the immune system operates and the reason we don't all suffer from serious self-attack conditions," stated the head of the Nobel Committee.

This team's studies explain a core mystery: How does the defense system protect us from numerous invaders while keeping our healthy cells unharmed?

Our body's protection system employs white blood cells that search for signs of infection, including pathogens and germs it has never encountered.

Such defenders employ detectors—called recognition units—that are produced randomly in a vast number of combinations.

This gives the immune system the capacity to combat a wide array of invaders, but the randomness of the mechanism unavoidably creates immune cells that can target the host.

Protectors of the Body

Researchers earlier understood that some of these harmful white blood cells were eliminated in the immune organ—where white blood cells mature.

This year's Nobel Prize recognizes the identification of regulatory T-cells—known as the immune system's "peacekeepers"—which patrol the body to neutralize other defenders that assault the body's own tissues.

It is known that this process fails in autoimmune diseases such as juvenile diabetes, MS, and RA.

A Nobel panel added, "The findings have established a novel area of investigation and spurred the creation of innovative therapies, for instance for cancer and autoimmune diseases."

Regarding cancer, T-regs block the system from fighting the tumor, so research are focused on reducing their quantity.

For autoimmune diseases, trials are exploring boosting regulatory T-cells so the organism is no longer under attack. A similar approach could also be useful in reducing the chances of transplanted organ rejection.

Pioneering Experiments

Prof Shimon Sakaguchi, of a Japanese institution, performed experiments on mice that had their immune gland removed, causing self-attack conditions.

The researcher demonstrated that introducing immune cells from other animals could stop the illness—implying there was a mechanism for blocking immune cells from harming the body.

Dr. Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were investigating an inherited immune disorder in rodents and humans that resulted in the identification of a gene critical for the way regulatory T-cells function.

"The groundbreaking work has revealed how the immune system is controlled by T-reg cells, preventing it from mistakenly targeting the healthy cells," commented a prominent biological science specialist.

"This work is a striking illustration of how basic physiological research can have far-reaching implications for public health."